# Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects

> **NCT02182388** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 82 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** BI 207127 NA powder for solution
- **DRUG:** BI 207127 NA tablet

## Key facts

- **NCT ID:** NCT02182388
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182388, "Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02182388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*